|
|
PREFACE |
|
S1 |
|
Full Article (PDF)
|
|
ACKNOWLEDGEMENTS |
|
S4 |
Irwin Goldstein,
Harin Padma-Nathan & Ray Rosen
|
Full Article (PDF)
|
|
BASIC SCIENCE RESEARCH |
Sympathetic pathways and adrenergic innervation of the penis |
S5 |
K-E Andersson,
P Hedlund & P Alm
|
Abstract
Full Article (PDF)
|
|
Central noradrenergic control of penile erection |
S13 |
F Giuliano & O Rampin
|
Abstract
Full Article (PDF)
|
|
Regulation of pre-synaptic alpha adrenergic activity in the corpus cavernosum |
S20 |
I Saenz de Tejada,
NN Kim,
I Goldstein & AM Traish
|
Abstract
Full Article (PDF)
|
|
Alpha-adrenergic receptor blockade by phentolamine increases the efficacy of vasodilators in penile corpus cavernosum |
S26 |
NN Kim,
I Goldstein,
RB Moreland & AM Traish
|
Abstract
Full Article (PDF)
|
|
Abanoquil, a new alpha-1 adrenoceptor antagonist. In vitro and in vivo effect on erectile tissue |
S37 |
A Giraldi,
M Wyllie & G Wagner
|
Abstract
Full Article (PDF)
|
|
Cyclic AMP regulates mRNA expression of alpha-1d and alpha-2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cells |
S41 |
A Traish,
NN Kim,
Y-H Huang,
I Goldstein & RB Moreland
|
Abstract
Full Article (PDF)
|
|
Role of alpha adrenergic receptors in erectile function |
S48 |
A Traish,
NN Kim,
RB Moreland & I Goldstein
|
Abstract
Full Article (PDF)
|
|
CLINICAL RESEARCH |
Effects of alpha-2 blockade on sexual response: experimental studies with Delequamine (RS15385) |
S64 |
J Bancroft
|
Abstract
Full Article (PDF)
|
|
Yohimbine in erectile dysfunction: the facts |
S70 |
A Morales
|
Abstract
Full Article (PDF)
|
|
Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction |
S75 |
I Goldstein
|
Abstract
Full Article (PDF)
|
|
Comparison of oral and intracavernosal vasoactive agents in penile erection |
S81 |
T Lue,
I Goldstein & A Traish
|
Abstract
Full Article (PDF)
|
|